CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 14-Deoxy-11,12-didehydroandrographolide
Accession: CHEBI:69808
browse the term
Definition: A diterpene lactone that has formula C20H28O4.
Synonyms: related_synonym: 3-{(E)-2-[(1R,4aS,5R,6R,8aR)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]vinyl}-2(5H)-furanone; Formula=C20H28O4; InChI=1S/C20H28O4/c1-13-4-7-16-19(2,10-8-17(22)20(16,3)12-21)15(13)6-5-14-9-11-24-18(14)23/h5-6,9,15-17,21-22H,1,4,7-8,10-12H2,2-3H3/b6-5+/t15-,16+,17-,19+,20+/m1/s1; InChIKey=XMJAJFVLHDIEHF-CRBRZBHVSA-N; SMILES=[H][C@]12CCC(=C)[C@@H](\\C=C\\C3=CCOC3=O)[C@]1(C)CC[C@@H](O)[C@@]2(C)CO
xref_mesh: MESH:C495626
xref: PMID:21598983
G
Aaas
aladin WD repeat nucleoporin
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of AAAS mRNA
CTD
PMID:22101062
NCBI chr 7:133,464,315...133,483,961
Ensembl chr 7:133,464,315...133,483,961
G
Acp2
acid phosphatase 2, lysosomal
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ACP2 mRNA
CTD
PMID:22101062
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
G
Adrm1
ADRM1 26S proteasome ubiquitin receptor
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ADRM1 mRNA
CTD
PMID:22101062
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
G
Ajuba
ajuba LIM protein
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of AJUBA mRNA
CTD
PMID:22101062
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
G
Ak1
adenylate kinase 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of AK1 mRNA
CTD
PMID:22101062
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Akap1
A-kinase anchoring protein 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of AKAP1 mRNA
CTD
PMID:22101062
NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896
G
Akr7a2
aldo-keto reductase family 7, member A2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of AKR7A2 mRNA
CTD
PMID:22101062
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Aldoa
aldolase, fructose-bisphosphate A
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ALDOA mRNA
CTD
PMID:22101062
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Ank3
ankyrin 3
decreases expression increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ANK3 mRNA 14-deoxy-11,12-didehydroandrographolide results in increased expression of ANK3 mRNA
CTD
PMID:22101062
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
G
Arhgap5
Rho GTPase activating protein 5
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ARHGAP5 mRNA
CTD
PMID:22101062
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Arid4a
AT-rich interaction domain 4A
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of ARID4A mRNA
CTD
PMID:22101062
NCBI chr 6:89,522,459...89,593,868
Ensembl chr 6:89,522,442...89,593,510
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ARIH2 mRNA
CTD
PMID:22101062
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ASXL1 mRNA
CTD
PMID:22101062
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Atp5f1d
ATP synthase F1 subunit delta
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ATP5F1D mRNA
CTD
PMID:22101062
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
G
Atp6v0d1
ATPase H+ transporting V0 subunit D1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ATP6V0D1 mRNA
CTD
PMID:22101062
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
G
Atp6v1c1
ATPase H+ transporting V1 subunit C1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ATP6V1C1 mRNA
CTD
PMID:22101062
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
G
Bag1
BAG cochaperone 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of BAG1 mRNA
CTD
PMID:22101062
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
G
Bclaf1
BCL2-associated transcription factor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of BCLAF1 mRNA
CTD
PMID:22101062
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
G
Bloc1s1
biogenesis of lysosomal organelles complex-1, subunit 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of BLOC1S1 mRNA
CTD
PMID:22101062
NCBI chr 7:1,347,495...1,351,103
Ensembl chr 7:1,340,934...1,351,558
G
Caprin1
cell cycle associated protein 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CAPRIN1 mRNA
CTD
PMID:22101062
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
G
Car12
carbonic anhydrase 12
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CA12 mRNA
CTD
PMID:22101062
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]
CTD
PMID:27089844
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]
CTD
PMID:27089844
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccnb1ip1
cyclin B1 interacting protein 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CCNB1IP1 mRNA
CTD
PMID:22101062
NCBI chr15:24,014,905...24,031,357
Ensembl chr15:24,014,908...24,028,475
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CCND1 mRNA 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCND1 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CCND1 protein]]
CTD
PMID:22101062 PMID:30248417
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CCND3 mRNA
CTD
PMID:22101062
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccne1
cyclin E1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein]
CTD
PMID:30248417
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccng2
cyclin G2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CCNG2 mRNA
CTD
PMID:22101062
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cdc37
cell division cycle 37, HSP90 cochaperone
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CDC37 mRNA
CTD
PMID:22101062
NCBI chr 8:19,677,400...19,690,761
Ensembl chr 8:19,671,938...19,690,809
G
Cdk2
cyclin dependent kinase 2
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CDK2 protein]]
CTD
PMID:30248417
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk6
cyclin-dependent kinase 6
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK6 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CDK6 protein]]
CTD
PMID:30248417
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CDKN1B mRNA
CTD
PMID:22101062
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPB mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein]
CTD
PMID:30248417
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cenps
centromere protein S
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CENPS mRNA
CTD
PMID:22101062
NCBI chr 5:159,563,917...159,573,534
G
Cfl1
cofilin 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CFL1 mRNA
CTD
PMID:22101062
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Chd2
chromodomain helicase DNA binding protein 2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CHD2 mRNA
CTD
PMID:22101062
NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
G
Chtf8
chromosome transmission fidelity factor 8
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CHTF8 mRNA
CTD
PMID:22101062
NCBI chr19:34,782,005...34,792,306
Ensembl chr19:34,781,856...34,792,578
G
Clptm1
CLPTM1 regulator of GABA type A receptor forward trafficking
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CLPTM1 mRNA
CTD
PMID:22101062
NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092
G
Cope
COPI coat complex subunit epsilon
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of COPE mRNA
CTD
PMID:22101062
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CREB1 protein]
CTD
PMID:30248417
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of CXCL12 mRNA
CTD
PMID:22101062
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of CYP1A1 mRNA beta-Naphthoflavone promotes the reaction [14-deoxy-11,12-didehydroandrographolide results in increased expression of CYP1A1 mRNA]
CTD
PMID:21963808
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dcaf6
DDB1 and CUL4 associated factor 6
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of DCAF6 mRNA
CTD
PMID:22101062
NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of DDIT3 mRNA
CTD
PMID:22101062
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of DDIT4 mRNA
CTD
PMID:22101062
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Dhfr
dihydrofolate reductase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of DHFR mRNA
CTD
PMID:22101062
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Drg2
developmentally regulated GTP binding protein 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of DRG2 mRNA
CTD
PMID:22101062
NCBI chr10:45,255,512...45,269,971
Ensembl chr10:45,255,507...45,269,969
G
Dut
deoxyuridine triphosphatase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of DUT mRNA
CTD
PMID:22101062
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of EIF4EBP1 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of EIF4EBP1 protein]]
CTD
PMID:30248417
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elovl2
ELOVL fatty acid elongase 2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of ELOVL2 mRNA
CTD
PMID:22101062
NCBI chr17:23,544,598...23,584,855
Ensembl chr17:23,544,568...23,584,848
G
Eno1
enolase 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ENO1 mRNA
CTD
PMID:22101062
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Ewsr1
EWS RNA-binding protein 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of EWSR1 mRNA
CTD
PMID:22101062
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
G
Fasn
fatty acid synthase
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein]
CTD
PMID:30248417
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fbxo8
F-box protein 8
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of FBXO8 mRNA
CTD
PMID:22101062
NCBI chr16:33,665,305...33,711,215
Ensembl chr16:33,665,306...33,711,272
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of FEN1 mRNA
CTD
PMID:22101062
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fibp
FGF1 intracellular binding protein
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of FIBP mRNA
CTD
PMID:22101062
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
G
Fkbp1a
FKBP prolyl isomerase 1A
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of FKBP1A mRNA
CTD
PMID:22101062
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Flcn
folliculin
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of FLCN mRNA
CTD
PMID:22101062
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
G
Fnip1
folliculin interacting protein 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of FNIP1 mRNA
CTD
PMID:22101062
NCBI chr10:38,567,728...38,650,824
Ensembl chr10:38,567,729...38,650,824
G
Folr1
folate receptor alpha
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of FOLR1 mRNA
CTD
PMID:22101062
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
G
Fus
Fus RNA binding protein
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of FUS mRNA
CTD
PMID:22101062
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
G
Fzd7
frizzled class receptor 7
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of FZD7 mRNA
CTD
PMID:22101062
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of GADD45A mRNA
CTD
PMID:22101062
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gas5
growth arrest specific 5
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of GAS5 mRNA
CTD
PMID:22101062
NCBI chr13:73,303,611...73,306,932
G
Gfus
GDP-L-fucose synthase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of GFUS mRNA
CTD
PMID:22101062
NCBI chr 7:107,612,087...107,617,005
Ensembl chr 7:107,612,094...107,616,948
G
Gne
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of GNE mRNA
CTD
PMID:22101062
NCBI chr 5:58,267,189...58,307,396
Ensembl chr 5:58,267,210...58,307,499
G
Gpaa1
glycosylphosphatidylinositol anchor attachment 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of GPAA1 mRNA
CTD
PMID:22101062
NCBI chr 7:108,051,896...108,055,479
Ensembl chr 7:108,051,861...108,055,484
G
Gps1
G protein pathway suppressor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of GPS1 mRNA
CTD
PMID:22101062
NCBI chr10:106,050,323...106,055,407
Ensembl chr10:106,050,388...106,055,412
G
Gps2
G protein pathway suppressor 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of GPS2 mRNA
CTD
PMID:22101062
NCBI chr10:54,637,360...54,640,542
Ensembl chr10:54,637,455...54,640,650
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein]
CTD
PMID:30248417
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of GULP1 mRNA
CTD
PMID:22101062
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of H1-2 mRNA
CTD
PMID:22101062
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H2bc9
H2B clustered histone 9
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of H2BC9 mRNA
CTD
PMID:22101062
NCBI chr17:42,470,593...42,478,590
G
Hbp1
HMG-box transcription factor 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of HBP1 mRNA
CTD
PMID:22101062
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hells
helicase, lymphoid specific
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of HELLS mRNA
CTD
PMID:22101062
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of HERPUD1 mRNA
CTD
PMID:22101062
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hgsnat
heparan-alpha-glucosaminide N-acetyltransferase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of HGSNAT mRNA
CTD
PMID:22101062
NCBI chr16:66,105,233...66,137,444
Ensembl chr16:66,105,181...66,136,138
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of HMGCS2 mRNA
CTD
PMID:22101062
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of HNRNPA1 mRNA
CTD
PMID:22101062
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpd
heterogeneous nuclear ribonucleoprotein D
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of HNRNPD mRNA
CTD
PMID:22101062
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
G
Hoxb3
homeo box B3
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of HOXB3 mRNA
CTD
PMID:22101062
NCBI chr10:81,258,739...81,314,134
Ensembl chr10:81,299,357...81,313,107
G
Ifrd1
interferon-related developmental regulator 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of IFRD1 mRNA
CTD
PMID:22101062
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ifrd2
interferon-related developmental regulator 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of IFRD2 mRNA
CTD
PMID:22101062
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of IGFBP5 mRNA
CTD
PMID:22101062
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Il6
interleukin 6
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]
CTD
PMID:27089844
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Immp1l
inner mitochondrial membrane peptidase subunit 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of IMMP1L mRNA
CTD
PMID:22101062
NCBI chr 3:92,385,329...92,449,559
Ensembl chr 3:92,385,379...92,452,313
G
Ins1
insulin 1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCND1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK6 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPB mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SREBF1 mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SREBF1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CREB1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of EIF4EBP1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of PRKACA protein]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPS6KB1 protein]; [14-deoxy-11,12-didehydroandrographolide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPTOR protein; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CCND1 protein]]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CDK2 protein]]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CDK6 protein]]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of EIF4EBP1 protein]]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPS6KB1 protein]]; dorsomorphin inhibits the reaction [[14-deoxy-11,12-didehydroandrographolide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPTOR protein]
CTD
PMID:30248417
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Ints11
integrator complex subunit 11
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of INTS11 mRNA
CTD
PMID:22101062
NCBI chr 5:166,479,134...166,497,956
Ensembl chr 5:166,479,155...166,497,651
G
Itgb1bp1
integrin subunit beta 1 binding protein 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ITGB1BP1 mRNA
CTD
PMID:22101062
NCBI chr 6:40,820,693...40,836,074
Ensembl chr 6:40,821,339...40,836,037
G
Itpk1
inositol-tetrakisphosphate 1-kinase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of ITPK1 mRNA
CTD
PMID:22101062
NCBI chr 6:121,710,750...121,844,501
Ensembl chr 6:121,710,755...121,844,107
G
Jmy
junction mediating and regulatory protein, p53 cofactor
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of JMY mRNA
CTD
PMID:22101062
NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:24,668,854...24,731,006
G
Kcnk2
potassium two pore domain channel subfamily K member 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of KCNK2 mRNA
CTD
PMID:22101062
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Lgr4
leucine-rich repeat-containing G protein-coupled receptor 4
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of LGR4 mRNA
CTD
PMID:22101062
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
G
Lhx2
LIM homeobox 2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of LHX2 mRNA
CTD
PMID:22101062
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
G
Lmna
lamin A/C
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of LMNA mRNA
CTD
PMID:22101062
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
LOC103690190
histone H2A type 1-E
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of H2AC6 mRNA
CTD
PMID:22101062
NCBI chr17:42,707,954...42,708,420
G
Lrrn3
leucine rich repeat neuronal 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of LRRN3 mRNA
CTD
PMID:22101062
NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330
G
Lsr
lipolysis stimulated lipoprotein receptor
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of LSR mRNA
CTD
PMID:22101062
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of MANF mRNA
CTD
PMID:22101062
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein]
CTD
PMID:30248417
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk13
mitogen activated protein kinase 13
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of MAPK13 mRNA
CTD
PMID:22101062
NCBI chr20:6,835,277...6,845,500
Ensembl chr20:6,835,320...6,844,222
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein]
CTD
PMID:30248417
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of MCL1 mRNA
CTD
PMID:22101062
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of MCM2 mRNA
CTD
PMID:22101062
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of MCM3 mRNA
CTD
PMID:22101062
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Msto1
misato mitochondrial distribution and morphology regulator 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of MSTO1 mRNA
CTD
PMID:22101062
NCBI chr 2:174,305,945...174,310,230
Ensembl chr 2:174,301,861...174,310,216
G
Mtss1
MTSS I-BAR domain containing 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of MTSS1 mRNA
CTD
PMID:22101062
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
G
Mxi1
MAX interactor 1, dimerization protein
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of MXI1 mRNA
CTD
PMID:22101062
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
G
Mybl2
MYB proto-oncogene like 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of MYBL2 mRNA
CTD
PMID:22101062
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of MYC mRNA
CTD
PMID:22101062
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nabp2
nucleic acid binding protein 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of NABP2 mRNA
CTD
PMID:22101062
NCBI chr 7:830,949...836,551
Ensembl chr 7:830,949...838,027
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of NAMPT mRNA
CTD
PMID:22101062
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nbl1
NBL1, DAN family BMP antagonist
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of NBL1 mRNA
CTD
PMID:22101062
NCBI chr 5:151,318,752...151,329,948
Ensembl chr 5:151,318,754...151,338,719
G
Nck1
NCK adaptor protein 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of NCK1 mRNA
CTD
PMID:22101062
NCBI chr 8:101,018,610...101,079,237
Ensembl chr 8:101,018,702...101,079,300
G
Nfat5
nuclear factor of activated T-cells 5
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of NFAT5 mRNA
CTD
PMID:22101062
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nherf1
NHERF family PDZ scaffold protein 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of NHERF1 mRNA
CTD
PMID:22101062
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
G
Nmu
neuromedin U
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of NMU mRNA
CTD
PMID:22101062
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of NUPR1 mRNA
CTD
PMID:22101062
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Olfm1
olfactomedin 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of OLFM1 mRNA
CTD
PMID:22101062
NCBI chr 3:11,520,522...11,558,240
Ensembl chr 3:11,520,729...11,558,239
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:22101062
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
G
Pkm
pyruvate kinase M1/2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PKM mRNA
CTD
PMID:22101062
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plxnb2
plexin B2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PLXNB2 mRNA
CTD
PMID:22101062
NCBI chr 7:120,232,276...120,258,385
Ensembl chr 7:120,232,331...120,258,330
G
Pola1
DNA polymerase alpha 1, catalytic subunit
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of POLA1 mRNA
CTD
PMID:22101062
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]
CTD
PMID:30248417
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppfia1
PTPRF interacting protein alpha 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of PPFIA1 mRNA
CTD
PMID:22101062
NCBI chr 1:199,641,277...199,718,371
Ensembl chr 1:199,641,277...199,717,277
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PPP1CA mRNA
CTD
PMID:22101062
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
G
Prcp
prolylcarboxypeptidase
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of PRCP mRNA
CTD
PMID:22101062
NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of PRKACA protein]
CTD
PMID:30248417
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prkcsh
protein kinase C substrate 80K-H
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PRKCSH mRNA
CTD
PMID:22101062
NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492
G
Prlr
prolactin receptor
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of PRLR mRNA
CTD
PMID:22101062
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prrg4
proline rich and Gla domain 4
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PRRG4 mRNA
CTD
PMID:22101062
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Psen2
presenilin 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PSEN2 mRNA
CTD
PMID:22101062
NCBI chr13:91,967,506...91,993,240
Ensembl chr13:91,967,983...91,993,174
G
Psmc3
proteasome 26S subunit, ATPase 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PSMC3 mRNA
CTD
PMID:22101062
NCBI chr 3:77,031,825...77,037,207
Ensembl chr 3:77,031,825...77,043,358
G
Pspc1
paraspeckle component 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of PSPC1 mRNA
CTD
PMID:22101062
NCBI chr15:30,828,617...30,911,315
Ensembl chr15:30,828,626...30,911,202
G
Ptprk
protein tyrosine phosphatase, receptor type, K
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of PTPRK mRNA
CTD
PMID:22101062
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
G
Rab27b
RAB27B, member RAS oncogene family
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RAB27B mRNA
CTD
PMID:22101062
NCBI chr18:63,597,554...63,794,124
Ensembl chr18:63,600,937...63,757,180
G
Rangap1
RAN GTPase activating protein 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of RANGAP1 mRNA
CTD
PMID:22101062
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
G
Rbm10
RNA binding motif protein 10
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of RBM10 mRNA
CTD
PMID:22101062
NCBI chr X:1,540,399...1,572,571
Ensembl chr X:1,540,398...1,572,575
G
Rbm47
RNA binding motif protein 47
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RBM47 mRNA
CTD
PMID:22101062
NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431
G
Rcbtb1
RCC1 and BTB domain containing protein 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RCBTB1 mRNA
CTD
PMID:22101062
NCBI chr15:33,319,586...33,362,421
Ensembl chr15:33,319,586...33,365,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased activity of and affects the localization of RELA protein]
CTD
PMID:27089844
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rffl
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RFFL mRNA
CTD
PMID:22101062
NCBI chr10:67,740,711...67,803,669
Ensembl chr10:67,740,712...67,824,434
G
Rhod
ras homolog family member D
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of RHOD mRNA
CTD
PMID:22101062
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
G
Rit1
Ras-like without CAAX 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RIT1 mRNA
CTD
PMID:22101062
NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:174,180,848...174,195,455
G
Rorc
RAR-related orphan receptor C
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RORC mRNA
CTD
PMID:22101062
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPS6KB1 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPS6KB1 protein]]
CTD
PMID:30248417
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Rptor
regulatory associated protein of MTOR, complex 1
multiple interactions
ISO
[14-deoxy-11,12-didehydroandrographolide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPTOR protein; dorsomorphin inhibits the reaction [[14-deoxy-11,12-didehydroandrographolide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RPTOR protein]
CTD
PMID:30248417
NCBI chr10:104,878,487...105,176,986
Ensembl chr10:104,878,487...105,176,983
G
Rsrc2
arginine and serine rich coiled-coil 2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of RSRC2 mRNA
CTD
PMID:22101062
NCBI chr12:32,839,840...32,859,820
Ensembl chr12:32,839,809...32,859,799
G
Rtkn
rhotekin
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of RTKN mRNA
CTD
PMID:22101062
NCBI chr 4:115,640,813...115,657,952
Ensembl chr 4:115,640,774...115,657,952
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SCARB1 mRNA
CTD
PMID:22101062
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scd
stearoyl-CoA desaturase
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 protein]
CTD
PMID:30248417
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sel1l
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SEL1L mRNA
CTD
PMID:22101062
NCBI chr 6:110,735,450...110,779,695
Ensembl chr 6:110,735,450...110,779,648
G
Sertad2
SERTA domain containing 2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SERTAD2 mRNA
CTD
PMID:22101062
NCBI chr14:94,733,637...94,838,200
Ensembl chr14:94,733,579...94,838,313
G
Sf1
splicing factor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SF1 mRNA
CTD
PMID:22101062
NCBI chr 1:203,670,016...203,683,432
Ensembl chr 1:203,670,018...203,684,330
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SFPQ mRNA
CTD
PMID:22101062
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sfxn2
sideroflexin 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SFXN2 mRNA
CTD
PMID:22101062
NCBI chr 1:245,447,014...245,459,312
Ensembl chr 1:245,447,015...245,468,411 Ensembl chr 1:245,447,015...245,468,411
G
Sfxn4
sideroflexin 4
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SFXN4 mRNA
CTD
PMID:22101062
NCBI chr 1:259,976,480...259,998,778
Ensembl chr 1:259,976,481...259,998,754
G
Sigmar1
sigma non-opioid intracellular receptor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SIGMAR1 mRNA
CTD
PMID:22101062
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
G
Slc35a4
solute carrier family 35, member A4
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SLC35A4 mRNA
CTD
PMID:22101062
NCBI chr18:28,280,483...28,284,610
Ensembl chr18:28,279,750...28,284,725
G
Slc39a3
solute carrier family 39 member 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SLC39A3 mRNA
CTD
PMID:22101062
NCBI chr 7:8,676,845...8,682,846
Ensembl chr 7:8,676,759...8,685,149
G
Slitrk4
SLIT and NTRK-like family, member 4
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SLITRK4 mRNA
CTD
PMID:22101062
NCBI chr X:142,706,495...142,718,968
Ensembl chr X:142,706,338...142,718,575
G
Snf8
SNF8 subunit of ESCRT-II
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SNF8 mRNA
CTD
PMID:22101062
NCBI chr10:80,984,337...80,996,724
Ensembl chr10:80,984,363...80,996,734
G
Snx16
sorting nexin 16
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SNX16 mRNA
CTD
PMID:22101062
NCBI chr 2:91,335,896...91,357,622
Ensembl chr 2:91,336,092...91,357,619
G
Sowahc
sosondowah ankyrin repeat domain family member C
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SOWAHC mRNA
CTD
PMID:22101062
NCBI chr20:27,195,198...27,199,664
Ensembl chr20:27,193,743...27,265,018 Ensembl chr20:27,193,743...27,265,018
G
Spire1
spire-type actin nucleation factor 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SPIRE1 mRNA
CTD
PMID:22101062
NCBI chr18:61,041,914...61,171,670
Ensembl chr18:61,041,290...61,171,899
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SREBF1 mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SREBF1 protein]
CTD
PMID:30248417
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srm
spermidine synthase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SRM mRNA
CTD
PMID:22101062
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srpk2
SRSF protein kinase 2
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of SRPK2 mRNA
CTD
PMID:22101062
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srrt
serrate, RNA effector molecule
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SRRT mRNA
CTD
PMID:22101062
NCBI chr12:19,392,578...19,406,098
Ensembl chr12:19,392,625...19,406,095
G
Srsf1
serine and arginine rich splicing factor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SRSF1 mRNA
CTD
PMID:22101062
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
G
Srsf2
serine and arginine rich splicing factor 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SRSF2 mRNA
CTD
PMID:22101062
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of SFRS3 mRNA
CTD
PMID:22101062
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Stard10
StAR-related lipid transfer domain containing 10
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of STARD10 mRNA
CTD
PMID:22101062
NCBI chr 1:155,722,637...155,748,007
Ensembl chr 1:155,718,389...155,747,094
G
Stx3
syntaxin 3
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of STX3 mRNA
CTD
PMID:22101062
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
G
Tbrg1
transforming growth factor beta regulator 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of TBRG1 mRNA
CTD
PMID:22101062
NCBI chr 8:37,355,274...37,362,933
Ensembl chr 8:37,354,658...37,362,930
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of TCAF1 mRNA
CTD
PMID:22101062
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tfap2a
transcription factor AP-2 alpha
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of TFAP2A mRNA
CTD
PMID:22101062
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tff1
trefoil factor 1
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of TFF1 mRNA
CTD
PMID:22101062
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Thsd4
thrombospondin type 1 domain containing 4
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of THSD4 mRNA
CTD
PMID:22101062
NCBI chr 8:60,384,636...60,984,419
Ensembl chr 8:60,386,875...61,024,995
G
Tipin
timeless interacting protein
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of TIPIN mRNA
CTD
PMID:22101062
NCBI chr 8:64,780,813...64,801,358
Ensembl chr 8:64,780,828...64,801,352
G
Tk1
thymidine kinase 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of TK1 mRNA
CTD
PMID:22101062
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tnf
tumor necrosis factor
multiple interactions
ISO
14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased activity of and affects the localization of RELA protein]; 14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; 14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; 14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; 14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]
CTD
PMID:27089844
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53i3
tumor protein p53 inducible protein 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of TP53I3 mRNA
CTD
PMID:22101062
NCBI chr 6:27,818,327...27,825,753
G
Trak2
trafficking kinesin protein 2
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of TRAK2 mRNA
CTD
PMID:22101062
NCBI chr 9:60,348,531...60,414,036
Ensembl chr 9:60,350,012...60,413,996
G
Tyms
thymidylate synthetase
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of TYMS mRNA
CTD
PMID:22101062
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ufd1
ubiquitin recognition factor in ER associated degradation 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of UFD1 mRNA
CTD
PMID:22101062
NCBI chr11:82,161,618...82,185,107
Ensembl chr11:82,161,619...82,185,087
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of VTCN1 mRNA
CTD
PMID:22101062
NCBI chr 2:188,253,594...188,321,658
Ensembl chr 2:188,253,594...188,321,658
G
Wdr26
WD repeat domain 26
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of WDR26 mRNA
CTD
PMID:22101062
NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295
G
Wt1
WT1 transcription factor
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of WT1 mRNA
CTD
PMID:22101062
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
G
Yipf3
Yip1 domain family, member 3
decreases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in decreased expression of YIPF3 mRNA
CTD
PMID:22101062
NCBI chr 9:14,730,289...14,735,644
Ensembl chr 9:14,730,284...14,735,641
G
Yipf5
Yip1 domain family, member 5
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of YIPF5 mRNA
CTD
PMID:22101062
NCBI chr18:32,123,814...32,136,947
Ensembl chr18:32,123,842...32,157,642
G
Zyg11b
zyg-11 family member B, cell cycle regulator
increases expression
ISO
14-deoxy-11,12-didehydroandrographolide results in increased expression of ZYG11B mRNA
CTD
PMID:22101062
NCBI chr 5:122,985,548...123,042,735
Ensembl chr 5:122,992,147...123,042,736
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all